Skip to main content
Id Year Reporting type Decision Issue Request by parties to TEAP Report to be produced
0 2021 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2021 progress report
1 2021 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2021 progress report
2 2021 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2021 progress report
3 2021 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2021 interim report (only upon submission of nominations)
4 2021 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2021 final report (only upon submission of nominations)
5 2021 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2021 progress report (only upon submission of nominations)
6 2021 Thematic reports XXX/6 Destruction technologies Decision XXX/6 – Assess those destruction technologies listed in annex II to the report of the 30th MOP as not approved or not determined, as well as any other technologies, and to report to the 33rd MOP, with the understanding that, if further information is provided by parties in due time, in particular regarding the destruction of Annex F, group II, substances by cement kilns, the Panel should report to an earlier meeting of OEWG 2021 progress report
7 2021 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2021 progress report (only if new compelling information becomes available)
8 2021 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2021 progress report (only if new compelling information becomes available)
9 2021 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
10 2022 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2022 progress report
11 2022 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2022 progress report
12 2022 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2022 progress report
13 2022 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2022 interim report (only upon submission of nominations)
14 2022 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2022 final report (only upon submission of nominations)
15 2022 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2022 progress report (only upon submission of nominations)
16 2022 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report TEAP 2022 quadrennial assessment report
17 2022 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report TEAP 2022 quadrennial assessment reports
18 2022 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
19 2022 Periodic assessments XXXI/2 Quadrennial assessment Decision XXXI/2 – Prepare the TEAP 2022 quadrennial assessment TEAP and TOCs 2022 quadrennial assessment reports (6)
20 2022 Periodic assessments XXIX/12 HFCs not listed in Annex F to the Montreal Protocol Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F TEAP and TOCs 2022 quadrennial assessment reports (6)
21 2022 Periodic assessments XXX/2 HCFC availability Decision XXX/2 – Provide in its quadrennial reports to be presented to the 35th MOP, in 2023, and to the 39th MOP, in 2027, information on the availability of Annex C, group I, substances, including amounts available from recovery, recycling and reclamation, and best available information on country-level and total known stocks, as well as the availability of alternative options for the applications described in Article 2F, paragraphs 6 (a) and 6 (b) TEAP and TOCs 2022 quadrennial assessment reports (6)
22 2022 Periodic assessments XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 4 – Conduct periodic reviews of alternatives to HFCs in 2022 and every five years thereafter, and provide technological and economic assessments of the latest available and emerging alternatives to HFCs (first review) Report on the review of alternatives to HFCs
23 2023 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2023 progress report
24 2023 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2023 progress report
25 2023 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2023 progress report
26 2023 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations in accordance with the criteria established in the decision (and other relevant decisions) 2023 interim report (only upon submission of nominations)
27 2023 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations in accordance with the criteria established in the decision (and other relevant decisions) 2023 final report (only upon submission of nominations)
28 2023 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2023 progress report (only upon submission of nominations)
29 2023 Thematic reports XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors Report on technology review
30 2023 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2023 progress report (only if new compelling information becomes available)
31 2023 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2023 progress report (only if new compelling information becomes available)
32 2023 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
33 2023 Periodic assessments Replenishment study for 2024–2026 Expected decision at the 34th MOP, in 2022, and potential additional guidance by OEWG (45th meeting) in 2023 – Prepare a report on the appropriate level of the 2024–2026 replenishment of the Multilateral Fund Replenishment task force report (2024–2026)
34 2023 Periodic assessments Replenishment study for 2024–2026 Expected decision at the 34th MOP, in 2022, and potential additional guidance by OEWG (45th meeting) in 2023 – Prepare a report on the appropriate level of the 2024–2026 replenishment of the Multilateral Fund Supplement to the replenishment task force report
35 2023 Periodic assessments Quadrennial assessment Expected decision at the 31st MOP, in 2019 – Prepare the assessment panels’ synthesis report 2022 quadrennial assessment synthesis report
36 2024 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2024 progress report
37 2024 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2024 progress report
38 2024 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2024 progress report
39 2024 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2024 interim report (only upon submission of nominations)
40 2024 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2024 final report (only upon submission of nominations)
41 2024 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2024 progress report (only upon submission of nominations)
42 2024 Thematic reports XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors Report on technology review
43 2024 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2024 progress report (only if new compelling information becomes available)
44 2024 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2024 progress report (only if new compelling information becomes available)
45 2024 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
46 2025 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2025 progress report
47 2025 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2025 progress report
48 2025 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2025 progress report
49 2025 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2025 interim report (only upon submission of nominations)
50 2025 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2025 final report (only upon submission of nominations)
51 2025 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2025 progress report (only upon submission of nominations)
52 2025 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2025 progress report (only if new compelling information becomes available)
53 2025 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2025 progress report (only if new compelling information becomes available)
54 2025 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
55 2026 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2026 progress report
56 2026 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2026 progress report
57 2026 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2026 progress report
58 2026 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2026 interim report (only upon submission of nominations)
59 2026 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2026 final report (only upon submission of nominations)
60 2026 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2026 progress report (only upon submission of nominations)
61 2026 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report TEAP 2026 quadrennial assessment report
62 2026 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report TEAP 2026 quadrennial assessment reports
63 2026 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
64 2026 Periodic assessments Replenishment study for 2027–2029 Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund Replenishment task force report (2027–2029)
65 2026 Periodic assessments Replenishment study for 2027–2029 Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund Supplement to the replenishment task force report
66 2026 Periodic assessments Quadrennial assessment Expected decision at the 35th MOP, in 2023 – Prepare the TEAP 2026 quadrennial assessment TEAP and TOCs 2026 quadrennial assessment reports (6)
67 2026 Periodic assessments XXIX/12 HFCs not listed in Annex F of the Montreal Protocol Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F TEAP and TOCs 2026 quadrennial assessment reports (6)
68 2026 Periodic assessments XXX/2 HCFC availability Decision XXX/2 – Provide in its quadrennial reports to be presented to the 35th MOP, in 2023, and to the 39th MOP, in 2027, information on the availability of Annex C, group I, substances, including amounts available from recovery, recycling and reclamation, and best available information on country-level and total known stocks, as well as the availability of alternative options for the applications described in Article 2F, paragraphs 6 (a) and 6 (b) TEAP and TOCs 2026 quadrennial assessment reports (6)
69 2027 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2027 progress report
70 2027 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2027 progress report
71 2027 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2027 progress report
72 2027 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2027 interim report (only upon submission of nominations)
73 2027 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2027 final report (only upon submission of nominations)
74 2027 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2027 progress report (only upon submission of nominations)
75 2027 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2027 progress report (only if new compelling information becomes available)
76 2027 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2027 progress report (only if new compelling information becomes available)
77 2027 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
78 2027 Periodic assessments Quadrennial assessment Expected decision at the 35th MOP, in 2023 – Prepare the assessment panels’ synthesis report 2026 quadrennial assessment synthesis report
79 2027 Periodic assessments XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 4 – Conduct periodic reviews of alternatives to HFCs in 2022 and every five years thereafter, and provide technological and economic assessments of the latest available and emerging alternatives to HFCs (second review) Report on review of alternatives to HFCs
80 2028 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2028 progress report
81 2028 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2028 progress report
82 2028 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2028 progress report
83 2028 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2028 interim report (only upon submission of nominations)
84 2028 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2028 final report (only upon submission of nominations)
85 2028 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2028 progress report (only upon submission of nominations)
86 2028 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2028 progress report (only if new compelling information becomes available)
87 2028 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2028 progress report (only if new compelling information becomes available)
88 2028 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
89 2028 Periodic assessments XXVIII/2 Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraphs 32 and 33 – Periodically assess the suitability of HFC alternatives for use at high ambient temperatures, starting four years from the HFC freeze date and every four years thereafter (first review) Assessment of high-ambient-temperature HFC alternatives
90 2029 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2029 progress report
91 2029 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2029 progress report
92 2029 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2029 progress report
93 2029 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2029 interim report (only upon submission of nominations)
94 2029 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2029 final report (only upon submission of nominations)
95 2029 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2029 progress report (only upon submission of nominations)
96 2029 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report 2029 progress report (only if new compelling information becomes available)
97 2029 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report 2029 progress report (only if new compelling information becomes available)
98 2029 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
99 2029 Periodic assessments Replenishment study for 2030–2032 Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund Replenishment task force report (2030–2032)
100 2029 Periodic assessments Replenishment study for 2030–2032 Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund Supplement to the replenishment task force report
101 2030 Progress updates IV/13 Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects 2030 progress report
102 2030 Progress updates XI/17 Technical progress update by TEAP and its TOCs Decision XI/17 – Report on any important new developments on an annual basis 2030 progress report
103 2030 Progress updates XXXI/8 Procedures relevant to nominations to the TEAP and its TOCs. Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements 2030 progress report
104 2030 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2030 interim report (only upon submission of nominations)
105 2030 Thematic reports IX/6 Critical-use nominations Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2030 final report (only upon submission of nominations)
106 2030 Thematic reports IV/25 Essential-use nominations Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision 2030 progress report (only upon submission of nominations)
107 2030 Thematic reports XXXI/5 Laboratory and analytical uses Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report TEAP 2030 quadrennial assessment report
108 2030 Thematic reports XXXI/6 Process agents Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report TEAP 2030 quadrennial assessment report
109 2030 Thematic reports XXX/15 Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances Review only if the specific conditions set out in decision XXX/15 are met
110 2030 Periodic assessments Quadrennial assessment Expected decision at the 39th MOP, in 2027 - Prepare the TEAP 2030 quadrennial assessment TEAP and TOCs 2030 quadrennial assessment reports (6)
111 2030 Periodic assessments XXIX/12 HFCs not listed in Annex F of the Montreal Protocol Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F TEAP and TOCs 2030 quadrennial assessment reports (6)
1 The provisions of decision XXX/15 regarding process agents and laboratory and analytical uses are superceded by decisions XXXI/6 and XXXI/5, respectively. The process of dealing with possible new substances is set out in decision IX/24.
2 Reports to be produced on the listed issues are not indicated herein given that the time at which the respective conditions set out in decision XXX/15 will be met is not known.
3 In case the review in response to decision XXVIII/2, para. 5, is conducted five years before 2028.
4 In case the review in response to decision XXVIII/2, para. 5, is conducted four years before 2028.